Peregrine Asset Advisers’s Vertex Pharmaceuticals VRTX Stock Holding History

Peregrine Asset Advisers’s Portfolio VRTX Stock Details VRTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$260K	Buy
2023 Q3	–	Sell
2023 Q2	$5.04M	Buy
2022 Q3	–	Sell
2022 Q2	$4.2M	Buy
2020 Q1	–	Sell
2019 Q4	$438	Buy
2018 Q4	–	Sell
2018 Q3	$2.61M	Buy
2017 Q4	–	Sell
2017 Q3	$4.31M	Buy